Lifecore Biomedical, Inc. (LFCR)
Lifecore Biomedical makes sterile injectable drugs and medical devices under contract for pharmaceutical and biotechnology companies. It last closed at $6.39 on Nov 17, down 0.39% on the day.
Analyst Ratings & Price Targets
Analyst Ratings →Based on 1 analyst who set a price target on LFCR in the past 90 days. The average target is $8.00, with a high of $8.00 and a low of $8.00, compared with the last close of $6.39.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 25 | Craig-Hallum | Initiated | Buy | $8 |
| Jun 16 | Barrington Research | Target raised | Buy | $5.50 → $6.50 |
| Mar 17 | Barrington Research | Upgrade | Buy | $5.50 |
Technical Analysis
The stock sits between its 20 and 50 day averages. It is 16% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 60). The nearest support is the Pivot S1 at $6.38, and the nearest resistance the Pivot at $6.40.
| RSI (14) | 60.36 | Strong, overbought above 70 | Neutral |
| MACD | 0.10 | Below its signal line | Bearish |
| Stochastic | 44.2 | Middle of its range | Neutral |
| ADX (14) | 30.2 | Trending up | |
| Williams %R | -65.0 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | -22.5 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −0.5% | Change over 10 sessions | Bearish |
| ATR (14) | $0.07 | Typical daily range, 1.1% of price |
| RSI (14) | 60.31 | Strong, overbought above 70 | Neutral |
| MACD | 0.28 | Above its signal line | Bullish |
| Stochastic | 90.2 | Near the top of its range | Overbought |
| ADX (14) | 23.4 | Weak trend | |
| Williams %R | -9.8 | Oversold below −80, overbought above −20 | Overbought |
| CCI (20) | 81.2 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +55.1% | Change over 10 sessions | Bullish |
| ATR (14) | $0.49 | Typical daily range, 7.6% of price |
What happened before
See how LFCR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How LFCR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in LFCR in the last 90 days.
LFCR Institutional Ownership
Full report →- ●48 buying vs 44 selling
- ●Shares held by funds +0.1%
- ▲Funds holding +5
- ●Superinvestors: 2 added, 2 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 105 | 100 | +5.0% |
| In funds' top 10 | 4 | 4 | 0.0% |
| Held by funds | – | – | – |
| New / increased | 16 / 32 | 15 / 35 | −4.0% |
| Reduced / sold out | 33 / 11 | 23 / 19 | +4.8% |
| Put/call ratio | – | 0.00 | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LFCR is in one of them and how their past LFCR trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered LFCR in an article yet. Here's the latest on the wider market.
About Lifecore Biomedical
Lifecore Biomedical is a contract development and manufacturing organization based in Chaska, Minnesota. It develops and makes sterile injectable drugs and medical devices, filled into syringes, vials and cartridges. The company also produces hyaluronic acid, made by fermentation, in bulk form and for use in injectables used in eye and joint treatments. Its customers include pharmaceutical, biotechnology and device companies that rely on its aseptic filling and regulatory expertise.
- Headquarters
- Chaska, MN



